skip to main content

Antitrust matters are rarely isolated within a single state or federal agency or jurisdiction. We represent clients facing multi-dimensional antitrust challenges on the transactional, regulatory and litigation fronts, mobilizing an unmatched combination of courtroom excellence, government experience and legal, economic and academic prowess on our clients’ behalf.

Client News

Cigna to Sell Group Life and Disability Insurance Business to New York Life in $6.3 Billion Deal

Paul, Weiss is advising Cigna Corporation on the regulatory clearance of the $6.3 billion sale of its group life and disability insurance business to New York Life.

» more

Firm News

Client News

Paul, Weiss Wins Fifth Circuit Appeal for Becton, Dickinson

Paul, Weiss won a major appeal in the Fifth Circuit on behalf of client Becton, Dickinson and Company (BD) in a long-running antitrust and false advertising litigation brought by competitor Retractable Technologies, Inc. (RTI). 

» more

Awards & Recognition

Scott Barshay and Rick Rule Recognized as “Dealmakers of the Year” by The American Lawyer

Corporate partner Scott Barshay and litigation partner Rick Rule have been named American Lawyer “Dealmakers of the Year.” 

» more

Client News

Cigna Secures DOJ Clearance of $67 Billion Express Scripts Acquisition

Cigna announced that the Antitrust Division of the DOJ cleared Cigna’s $67 billion acquisition of pharmacy benefits manager Express Scripts Holding.

» more

Client News

New York Judge Dismisses SSA Price-Fixing Class Action Against Nomura

In a victory for client Nomura and other defendant banks, Paul, Weiss and other joint defense firms won the dismissal of a consolidated class action alleging that Nomura and other major global financial institutions conspired to manipulate prices in the multitrillion-dollar global market for supranational, sub-sovereign and agency (SSA) bonds. 

» more

Client News

Landmark Antitrust Victory for Becton Dickinson in the Fifth Circuit

Paul, Weiss secured a significant antitrust appellate victory for global medical technology company Becton Dickinson & Company (BD).

» more

Client News

Elanco to Acquire Bayer’s Animal Health Business in $7.6 Billion Deal

Paul, Weiss is representing Elanco Animal Health Incorporated in its $7.6 billion cash-and-stock acquisition of the animal health business of Bayer AG, creating the world’s second-largest animal health business.

» more

© 2020 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy